Hippocampal chromatin-modifying enzymes are pivotal for scopolamine-induced synaptic plasticity gene expression changes and memory impairment

Journal of Neurochemistry

Volumn 134, Issue 4, 2015, Pages 642-651

  Singh, Padmanabh ^a   Konar, Arpita ^a   Kumar, Ashish ^a   Srivas, Sweta ^a   Thakur, Mahendra K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

amnesia; chromatin; DNMT1; HDAC2; scopolamine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BUTYRIC ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DECITABINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; HISTONE DEACETYLASE 2; HISTONE H3; HISTONE H3K14; HISTONE H3K9; SCOPOLAMINE; UNCLASSIFIED DRUG; CHROMATIN; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; HDAC2 PROTEIN, MOUSE; SCOPOLAMINE BROMIDE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARC GENE; ARTICLE; BDNF GENE; CONTROLLED STUDY; DNA METHYLATION; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HISTONE ACETYLATION; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; CHROMATIN; DRUG EFFECTS; ENZYMOLOGY; MEMORY DISORDER; PHYSIOLOGY;

ANIMALS; CHROMATIN; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HISTONE DEACETYLASE 2; MALE; MEMORY DISORDERS; MICE; NEURONAL PLASTICITY; SCOPOLAMINE HYDROBROMIDE;

EID: 84937812360     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13171     Document Type: Article

References (48)

1. Auld D. S., Kornecook T. J., Bastianetto S., and, Quirion R., (2002) Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog. Neurobiol. 68, 209-245.
2. Barak S., and, Weiner I., (2011) The M1/M4 preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia. Int. J. Neuropsychopharmacol. 14, 1233-1246.
3. Barrett R. M., and, Wood M. A., (2008) Beyond transcription factors: the role of chromatin modifying enzymes in regulating transcription required for memory. Learn. Mem. 15, 460-467.
4. Bradford M. M., (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Casu M. A., Wong T. P., De Koninck Y., Ribeiro-da-Silva A., and, Cuello A. C., (2002) Aging causes a preferential loss of cholinergic innervation of characterized neocortical pyramidal neurons. Cereb. Cortex 12, 329-337.
6. Cooper-Kuhn C. M., Winkler J., and, Kuhn H. G., (2004) Decreased neurogenesis after cholinergic forebrain lesion in the adult rat. J. Neurosci. Res. 77, 155-165.
7. Da silva P. F., Garcia V. A., Dornelles A. D. S., Da silva V. K., Maurmann N., Portal C. D., Ferreira R. D. P., Piazza F. C., Roesler R., and, der Schrö N., (2012) Memory impairment induced by brain iron overload isaccompanied by reduced h3k9 acetylation and ameliorated by sodium butyrate. Neuroscience. 200, 42-49.
8. Deiana S., Platt B., and, Riedel G., (2011) The cholinergic system and spatial learning. Behav. Brain Res. 221, 389-411.
9. Donat C. K., Schuhmann M. U., Voigt C., Nieber K., Deuther-Conrad W., and, Brust P., (2008) Time dependent alterations of cholinergic markers after experimental traumatic brain injury. Brain Res. 1246, 167-177.
10. Ellis J. R., Ellis K. A., Bartholomeusz C. F., Harrison B. J., Wesnes K. A., Erskine F. F., Vitetta L., and, Nathan P. J., (2006) Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int. J. Neuropsychopharmacol. 9, 175-189.
11. Feng J., Zhou Y., Campbell S. L., Le T., Li E., Sweatt J. D., Silva A. J., and, Fan G., (2010) Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat. Neurosci. 13, 423-430.
12. Gautam A., Wadhwa R., and, Thakur M. K., (2013) Involvement of hippocampal Arc in amnesia and its recovery by alcoholic extract of Ashwagandha leaves. Neurobiol. Learn. Mem. 106, 177-184.
13. Graff J., Rei D., Guan J. S., et al,. (2012) An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483, 222-226.
14. Guan J. S., Haggarty S. J., Giacometti E., et al,. (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459, 55-60.
15. Haense C., Kalbe E., Herholz K., Hohmann C., Neumaier B., Krais R., and, Heiss W. D., (2012) Cholinergic system function and cognition in mild cognitive impairment. Neurobiol. Aging 33, 867-877.
16. Intlekofer K. A., Berchtold N. C., Malvaez M., Carlos A. J., McQuown S. C., Cunningham M. J., Wood M. A., and, Cotman C. W., (2013) Exercise and sodium butyrate transform a subthreshold learning event into long-term memory via a brain-derived neurotrophic factor dependent mechanism. Neuropsychopharmacology 38, 2027-2034.
17. Jin B., and, Robertson K. D., (2013) DNA methyltransferases, DNA damage repair, and cancer. Adv. Exp. Med. Biol. 754, 3-29.
18. Jr Terry A. V., and, Buccafusco J. J., (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther. 306, 821-827.
19. Karmodiya K., Krebs A. R., Oulad-Abdelghani M., Kimura H., and, Tora L., (2012) H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells. BMC Genom. 13, 424.
20. Kidambi S., Yarmush J., Berdichevsky Y., Kamath S., Fong W., and, SchianodiCola J., (2010) Propofol induces MAPK/ERK cascade dependant expression of cFos and Egr-1 in rat hippocampal slices. BMC. Res. Notes 3, 201.
21. Kilgore M., Miller C. A., Fass D. M., Hennig K. M., Haggarty S. J., Sweatt J. D., and, Rumbaugh G., (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 35, 870-880.
22. Kishikawa S., Murata T., Kimura H., Shiota K., and, Yokoyama K. K., (2002) Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins. Eur. J. Biochem. 269, 2961-2970.
23. Klinkenberg I., and, Blokland A., (2010) The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci. Biobehav. Rev. 34, 1307-1350.
24. Konar A., Shah N., Singh R., Saxena N., Kaul S. C., Wadhwa R., and, Thakur M. K., (2011) Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS ONE 6, e27265. doi: 10.1371/journal.pone.0027265.
25. Kouzarides T., (2007) Chromatin modifications and their function. Cell 128, 693-705.
26. Kumar A., and, Thakur M. K., (2015) Epigenetic regulation of Presenilin 1 and 2 in the cerebral cortex of mice during development. Dev. Neurobiol. doi 10.1002/dneu.22274.
27. Loughery J. E., Dunne P. D., O'Neill K. M., Meehan R. R., Mc Daid J. R., and, Walsh C. P., (2011) DNMT1 deficiency triggers mismatch repair defects in human cells through depletion of repair protein levels in a process involving the DNA damage response. Hum. Mol. Genet. 20, 3241-3255.
28. Mitchell C. P., Chen Y., Kundakovic M., Costa E., and, Grayson D. R., (2005) Histone deacetylase inhibitors decrease reelin promoter methylation in vitro. J. Neurochem. 93, 483-492.
29. Mohn F., Weber M., Schubeler D., and, Roloff T., (2008) Methylated DNA Immunoprecipitation (MeDIP), in DNA Methylation Methods and Protocol (, Tost J., ed), 2nd edn, pp. 55-64. Springer Protocol Humana Press, New York.
30. Muller M. L., and, Bohnen N. I., (2013) Cholinergic dysfunction in Parkinson's disease. Curr. Neurol. Neurosci. Rep. 13, 377.
31. Park H. G., Yu H. S., Park S., Ahn Y. M., Kim Y. S., and, Kim S. H., (2014) Repeated treatment with electroconvulsiveseizures induces HDAC2 expression and down-regulation of NMDA receptor-related genes through histone deacetylation in the rat frontal cortex. Int. J. Neuropsychopharmacol. 17, 1487-1500.
32. Provenzano M. J., Fitzgerald M. P., Krager K., and, Domann F. E., (2007) Increased iodine uptake in thyroid carcinoma after treatment with sodium butyrate and decitabine (5-Aza-dC). Otolaryngol. Head Neck Sur. 137, 722-728.
33. Resende R. R., and, Adhikari A., (2009) Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation. Cell Commun. Signal. 7, 20.
34. Roth T. L., Lubin F. D., Sodhi M., and, Kleinman J. E., (2009) Epigenetic mechanisms in schizophrenia. Biochim. Biophys. Acta 1790, 869-877.
35. Ryu H., Lee J., Zaman K., Kubilis J., Ferrante R. J., Ross B. D., Neve R., and, Ratan R. R., (2003) Sp1and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J. Neurosci. 23, 3597-3606.
36. Sarkar S., Abujamra A. L., Loew J. E., Forman L. W., Perrine S. P., and, Faller D. V., (2011) Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. Anticancer Res. 31, 2723-2732.
37. Satta R., Maloku E., Zhubi A., Pibiri F., Hajos M., Costa E., and, Guidotti A., (2008) Nicotine decreases DNA methyltransferase 1expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Pros. Natl Acad. Sci. USA 105, 16356-16361.
38. Schliebs R., and, Arendt T., (2006) The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J. Neural. Transm. 113, 1625-1644.
39. Schliebs R., and, Arendt T., (2011) The cholinergic system in aging and neuronal degeneration. Behav. Brain Res. 22, 1555-1563.
40. Sharma B., and, Singh N., (2011) Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats. Psychopharmacology 215, 677-687.
41. Singh P., and, Thakur M. K., (2014) Reduced recognition memory is correlated with decrease in DNA methyltransferase1 and increase in histone deacetylase2 protein expression in old male mice. Biogerontology 15, 339-346.
42. Stefanko D. P., Barrett R. M., Ly A. R., Reolon G. K., and, Wood M. A., (2009) Modulation of long-term memory for object recognition via HDAC inhibition. Proc. Natl Acad. Sci. USA 106, 9447-9452.
43. Suply E., de Vries P., Soret R., Cossais F., and, Neunlist M., (2012) Butyrate enemas enhance both cholinergic and nitrergic phenotype of myenteric neurons and neuromuscular transmission in newborn rat colon. Am. J. Physiol. Gastrointest. Liver Physiol. 302, 1373-1380.
44. Thakur V. S., Deb G., Babcook M. A., and, Gupta S., (2014) Plant phytochemicals as epigenetic modulators: role in cancer chemoprevention. AAPS J. 16, 151-163.
45. Warnault V., Darcq E., Levine A., Barak S., and, Ron D., (2013) Chromatin remodeling-a novel strategy to control excessive alcohol drinking. Transl. Psychiatry. 3, e231. doi: 10.1038/tp.2013.4.
46. Zhao Z., Fan L., and, Frick K. M., (2010) Epigenetic alterations regulate estradiol induced enhancement of memory consolidation. Proc. Natl Acad. Sci. USA 107, 5605-5610.
47. Ziolkowska B., Urbanski M. J., Wawrzczak-Bargiela A., Bilecki W., and, Przewlocki R., (2005) Morphine activates Arc expression in the mouse striatum and in mouse neuroblastoma Neuro2A MOR1A cells expressing mu-opioid receptors. J. Neurosci. Res. 82, 563-570.
48. Zovkic I. B., Guzman-Karlsson M. C., and, Sweatt J. D., (2013) Epigenetic regulation of memory formation and maintenance. Learn. Mem. 20, 61-74.